QNTM

USFD

Consumer Stapleslarge cap
QNTM SCORE
43/100
LOW CONVICTION
top 42% of the universe

As of 2026-09-11, USFD scores 43out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. USFD trades at $95.34, 12% above the band ceiling.

USFD scores 43 out of 100 on QNTM's five-factor model — a low-conviction reading — at 43 the factor profile is among the weaker names in the universe. Its strongest factor is value at 73 (strong), where it screens cheap on the model's valuation inputs, followed by quality at 45. The weakest is momentum at 34, where price trend is the soft spot. Among Consumer Staples stocks it ranks in roughly the top 42% of the Consumer Staples names the model scores.

On valuation, USFD is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 46. Same-sector names the model rates nearby include MO, KDP, CART.

This is a descriptive factor read on USFD, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where USFD sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

Momentum34
Quality45
Value73
Volume40
Sentiment36

VALUATION RANGE

QNTM’s descriptive fair-value band for USFD runs $64.12–$85.50. Current price $95.34 sits 12% above the band ceiling. This is valuation context, not a price target.

See USFD update live, and set an alert when its conviction changes

QNTM rescores USFD and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

OTHER CONSUMER STAPLES NAMES

MO59KDP58CART56TGT54SJM53SYY53PM53DG52

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.